| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 287.18B | 276.21B | 293.56B | 214.79B | 209.26B | 202.55B |
| Gross Profit | 45.44B | 43.14B | 43.31B | 33.07B | 31.61B | 34.03B |
| EBITDA | 22.15B | 21.67B | 25.20B | 15.17B | 15.21B | 15.36B |
| Net Income | 11.43B | 11.03B | 15.60B | 7.92B | 7.25B | 8.28B |
Balance Sheet | ||||||
| Total Assets | 257.43B | 268.45B | 266.49B | 237.10B | 228.16B | 228.85B |
| Cash, Cash Equivalents and Short-Term Investments | 51.61B | 47.56B | 64.46B | 46.99B | 52.09B | 54.06B |
| Total Debt | 19.97B | 13.51B | 4.14B | 3.21B | 21.30B | 11.56B |
| Total Liabilities | 104.76B | 111.96B | 114.93B | 105.11B | 97.37B | 102.54B |
| Stockholders Equity | 144.47B | 148.05B | 144.03B | 125.79B | 124.70B | 121.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -25.17B | 16.85B | 2.63B | -10.86B | -1.30B |
| Operating Cash Flow | 0.00 | -21.22B | 20.74B | 4.81B | -8.54B | 973.00M |
| Investing Cash Flow | 0.00 | -4.98B | 2.15B | -1.75B | -1.07B | -6.91B |
| Financing Cash Flow | 0.00 | 1.91B | -5.54B | -9.82B | 6.00B | -1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥165.82B | 10.41 | ― | 2.03% | 6.69% | 29.94% | |
79 Outperform | ¥629.98B | 13.13 | ― | 2.13% | 15.98% | 82.99% | |
76 Outperform | ¥221.44B | 14.34 | 8.53% | 2.45% | 5.14% | -10.92% | |
66 Neutral | ¥6.04T | 42.68 | 9.46% | 1.52% | 1.60% | 5.80% | |
66 Neutral | ¥129.58B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | ¥479.49B | 16.11 | 1.44% | 4.80% | 0.68% | ― |